TG Therapeutics Shares Climb on Study Results
…
Philogen Announces Publication of Malignant Brain Tumor Study Results in Science Translational Medicine
(i) Research reveals Philogen's proprietary immunocytokines are powerful remedy for brain tumors. (ii) Early promising findings from Philogen's Section I/II review investigating the safety and efficacy of L19TNF monotherapy in...
Case Study: Li Lu’s Investment in Timberland
Incorporated in Li Lu's guide, "Civilization, Modernization, Value Expenditure and China," are two in depth situation experiments of his early investments, which he shared all through his 2006 lecture at...
Polaryx Therapeutics Receives IND Approval From the FDA to Study PLX-200 Treatment for Patients With Juvenile Neuronal Ceroid Lipofuscinosis
Push Launch - updated: Apr 8, 2020 PARAMUS, N.J., April 8, 2020(Newswire.com) - Polaryx Therapeutics, a biotech firm creating individual-welcoming, modest molecule therapeutics for lysosomal storage disorders, announced nowadays that...
New Study Reveals Professional Athletes Who Use the New Sleeprate Mobile App, Sleep Better than the General Population
Push Release - up-to-date: Feb 26, 2020 07:00 IST NEW YORK, February 26, 2020(Newswire.com) - A new scientific analyze from the Wingate Institute for Bodily Schooling and Sports has uncovered that...